BioCentury
ARTICLE | Company News

Access Pharmaceuticals, Norgine deal

November 24, 2014 8:00 AM UTC

PlasmaTech (formerly Access Pharmaceuticals Inc.) and Norgine added Australia and New Zealand to an August deal granting Norgine an exclusive license to commercialize, develop and manufacture MuGard ...